Meeting Banner
Abstract #4601

Associations between clinical risk factors, neurocognitive performance and brain activity in survivors of childhood Acute Lymphoblastic Leukemia treated on a chemotherapy-only protocol

Slim Fellah1, Matthew A. Scoggins1, Ping Zou1, Lisa M. Jacola2, Ching-Hon Pui3, Robert J. Ogg1, and Wilburn E. Reddick1

1Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, TN, United States, 2Psychology, St Jude Children's Research Hospital, Memphis, TN, United States, 3Oncology, St Jude Children's Research Hospital, Memphis, TN, United States

ALL survivors treated with chemotherapy alone remain at elevated risk for neurocognitive impairment. We used fMRI to investigate associations between clinical risk factors, neurocognitive performance and brain activity in survivors of ALL. Ninety-two survivors completed Verbal and Object N-back tasks during fMRI at end of therapy. Measures of working memory were completed as part of a neurocognitive evaluation. Working memory-related brain activation was associated with important clinical risk factors and neurocognitive performance. The pattern of behavioral and imaging responses provides evidence for both compromised and compensatory changes in regional brain function. fMRI may help in selecting patients for remedial intervention.

This abstract and the presentation materials are available to members only; a login is required.

Join Here